Phenothiazine‐induced systemic lupus erythematosus with superior vena cava syndrome: case report and review of the literature
- 1 July 1988
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 31 (7) , 923-926
- https://doi.org/10.1002/art.1780310716
Abstract
Phenothiazine‐induced lupus with circulating anticoagulant (CAC) has been reported infrequently, and is rarely associated with significant symptoms. We describe a patient who we suspect had perphenazine‐induced lupus erythematosus with CAC. She had recurrent episodes of venous thrombosis and ultimately developed superior vena cava syndrome. The relationships among phenothiazine‐induced lupus, CAC, and thrombosis are discussed.This publication has 17 references indexed in Scilit:
- Anticardiolipin antibodies: isotype distribution and phospholipid specificity.Annals of the Rheumatic Diseases, 1987
- Chlorpromazine-induced lupuslike diseaseJournal of the American Academy of Dermatology, 1985
- ANTICARDIOLIPIN ANTIBODIES: DETECTION BY RADIOIMMUNOASSAY AND ASSOCIATION WITH THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUSThe Lancet, 1983
- IgM Inhibitors of the Contact Activation Phase of Coagulation in Chlorpromazine‐ Treated PatientsBritish Journal of Haematology, 1978
- PERPHENAZINE-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS-LIKE SYNDROMEJournal of Nervous & Mental Disease, 1978
- A chlorpromazine‐induced inhibitor of blood coagulationAmerican Journal of Hematology, 1977
- Chlorpromazine-Induced Systemic Lupus ErythematosusJAMA, 1972
- Chlorpromazine-induced systemic lupus erythematosus: case report and review of the literatureJAMA, 1972
- CHLORPROMAZINE‐INDUCED ANTINUCLEAR FACTORSActa Medica Scandinavica, 1970